Migraine prevalence, disease burden, and the need for preventive therapy
- PMID: 17261680
- DOI: 10.1212/01.wnl.0000252808.97649.21
Migraine prevalence, disease burden, and the need for preventive therapy
Abstract
Objectives: 1) To reassess the prevalence of migraine in the United States; 2) to assess patterns of migraine treatment in the population; and 3) to contrast current patterns of preventive treatment use with recommendations for use from an expert headache panel.
Methods: A validated self-administered headache questionnaire was mailed to 120,000 US households, representative of the US population. Migraineurs were identified according to the criteria of the second edition of the International Classification of Headache Disorders. Guidelines for preventive medication use were developed by a panel of headache experts. Criteria for consider or offer prevention were based on headache frequency and impairment.
Results: We assessed 162,576 individuals aged 12 years or older. The 1-year period prevalence for migraine was 11.7% (17.1% in women and 5.6% in men). Prevalence peaked in middle life and was lower in adolescents and those older than age 60 years. Of all migraineurs, 31.3% had an attack frequency of three or more per month, and 53.7% reported severe impairment or the need for bed rest. In total, 25.7% met criteria for "offer prevention," and in an additional 13.1%, prevention should be considered. Just 13.0% reported current use of daily preventive migraine medication.
Conclusions: Compared with previous studies, the epidemiologic profile of migraine has remained stable in the United States during the past 15 years. More than one in four migraineurs are candidates for preventive therapy, and a substantial proportion of those who might benefit from prevention do not receive it.
Similar articles
-
Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.Neurology. 2019 Sep 10;93(11):500-509. doi: 10.1212/WNL.0000000000008105. Epub 2019 Aug 14. Neurology. 2019. PMID: 31413170 Free PMC article. Review.
-
Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.Headache. 2018 Oct;58(9):1408-1426. doi: 10.1111/head.13407. Epub 2018 Oct 20. Headache. 2018. PMID: 30341895
-
The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies.Headache. 2015 Jan;55(1):21-34. doi: 10.1111/head.12482. Headache. 2015. PMID: 25600719 Review.
-
Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study.Headache. 2007 Mar;47(3):355-63. doi: 10.1111/j.1526-4610.2006.00631.x. Headache. 2007. PMID: 17371352
-
Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) study.Cephalalgia. 2007 Mar;27(3):220-9. doi: 10.1111/j.1468-2982.2006.01275.x. Cephalalgia. 2007. PMID: 17263769
Cited by
-
Long-Term Outcome After Discontinuation of CGRP-Targeting Therapy for Migraine.Curr Pain Headache Rep. 2024 Apr 29. doi: 10.1007/s11916-024-01259-x. Online ahead of print. Curr Pain Headache Rep. 2024. PMID: 38683278 Review.
-
Unravelling the Genetic Landscape of Hemiplegic Migraine: Exploring Innovative Strategies and Emerging Approaches.Genes (Basel). 2024 Mar 31;15(4):443. doi: 10.3390/genes15040443. Genes (Basel). 2024. PMID: 38674378 Free PMC article. Review.
-
Headache in Multiple Sclerosis: A Narrative Review.Medicina (Kaunas). 2024 Mar 30;60(4):572. doi: 10.3390/medicina60040572. Medicina (Kaunas). 2024. PMID: 38674218 Free PMC article. Review.
-
Female-selective mechanisms promoting migraine.J Headache Pain. 2024 Apr 24;25(1):63. doi: 10.1186/s10194-024-01771-w. J Headache Pain. 2024. PMID: 38658853 Free PMC article. Review.
-
An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivity.J Headache Pain. 2024 Apr 18;25(1):59. doi: 10.1186/s10194-024-01749-8. J Headache Pain. 2024. PMID: 38637754 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous